Kazia Therapeutics Ownership 2024 | Who Owns Kazia Therapeutics Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.03%

0

Institutional Holders

6.00

Kazia Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY0.11%-197,850-3,700-1.84%61,294Mar 31, 2024
HSBC HOLDINGS PLC0.04%-63,956-36,238-36.17%20,114Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.03%-48,60035,900282.68%15,056Mar 31, 2024
XTX TOPCO LTD0.01%0.00%18,487-949-4.88%5,814Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.01%0.00%18,424-39,999-68.46%5,708Mar 31, 2024
RHUMBLINE ADVISERS0.01%-12,1702,46025.33%3,831,000Mar 31, 2024
GROUND SWELL CAPITAL, LLC0.01%0.00%11,15011,150100.00%3,507Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-500500100.00%155,000Mar 31, 2024
ALLWORTH FINANCIAL LP--87--27,000Mar 31, 2024
ADVISORNET FINANCIAL, INC--5--2,000Mar 31, 2024
JPMORGAN CHASE & CO--33100.00%1Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----18,682-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----140,166-100.00%-Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD----1,821,887-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----2,200-100.00%-Mar 31, 2024
ARMISTICE CAPITAL, LLC----2,475,555-100.00%-Mar 31, 2024
UBS GROUP AG----100-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----500-100.00%-Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.----85-100.00%-Mar 31, 2024

Kazia Therapeutics's largest institutional shareholder is MORGAN STANLEY, holding 0.11% of the company's total share outstanding, currently valued at $61.29K. The top 10 institutional shareholders own together 0.20% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GROUND SWELL CAPITAL, LLC0.01%0.00%11,15011,150100.00%3,507Mar 31, 2024
XTX TOPCO LTD0.01%0.00%18,487-949-4.88%5,814Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.01%0.00%18,424-39,999-68.46%5,708Mar 31, 2024
HSBC HOLDINGS PLC0.04%-63,956-36,238-36.17%20,114Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.03%-48,60035,900282.68%15,056Mar 31, 2024
MORGAN STANLEY0.11%-197,850-3,700-1.84%61,294Mar 31, 2024
RHUMBLINE ADVISERS0.01%-12,1702,46025.33%3,831,000Mar 31, 2024
ADVISORNET FINANCIAL, INC--5--2,000Mar 31, 2024
ALLWORTH FINANCIAL LP--87--27,000Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-500500100.00%155,000Mar 31, 2024
JPMORGAN CHASE & CO--33100.00%1Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----18,682-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----140,166-100.00%-Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD----1,821,887-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----2,200-100.00%-Mar 31, 2024
ARMISTICE CAPITAL, LLC----2,475,555-100.00%-Mar 31, 2024
UBS GROUP AG----100-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----500-100.00%-Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.----85-100.00%-Mar 31, 2024

The largest Kazia Therapeutics shareholder by % of total assets is GROUND SWELL CAPITAL, LLC. The company owns 11.15K shares of Kazia Therapeutics (KZIA), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BNP PARIBAS ARBITRAGE, SNC0.03%-48,60035,900282.68%15,056Mar 31, 2024
GROUND SWELL CAPITAL, LLC0.01%0.00%11,15011,150100.00%3,507Mar 31, 2024
RHUMBLINE ADVISERS0.01%-12,1702,46025.33%3,831,000Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-500500100.00%155,000Mar 31, 2024
JPMORGAN CHASE & CO--33100.00%1Mar 31, 2024
ALLWORTH FINANCIAL LP--87--27,000Mar 31, 2024
ADVISORNET FINANCIAL, INC--5--2,000Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.----85-100.00%-Mar 31, 2024
UBS GROUP AG----100-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----500-100.00%-Mar 31, 2024
XTX TOPCO LTD0.01%0.00%18,487-949-4.88%5,814Mar 31, 2024
CITADEL ADVISORS LLC----2,200-100.00%-Mar 31, 2024
MORGAN STANLEY0.11%-197,850-3,700-1.84%61,294Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----18,682-100.00%-Mar 31, 2024
HSBC HOLDINGS PLC0.04%-63,956-36,238-36.17%20,114Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.01%0.00%18,424-39,999-68.46%5,708Mar 31, 2024
BANK OF MONTREAL /CAN/----140,166-100.00%-Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD----1,821,887-100.00%-Mar 31, 2024
ARMISTICE CAPITAL, LLC----2,475,555-100.00%-Mar 31, 2024

As of Mar 31 2024, Kazia Therapeutics's largest institutional buyer is BNP PARIBAS ARBITRAGE, SNC. The company purchased 35.90K stocks of KZIA, valued at $15.06K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----2,475,555-100.00%-Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD----1,821,887-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----140,166-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.01%0.00%18,424-39,999-68.46%5,708Mar 31, 2024
HSBC HOLDINGS PLC0.04%-63,956-36,238-36.17%20,114Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----18,682-100.00%-Mar 31, 2024
MORGAN STANLEY0.11%-197,850-3,700-1.84%61,294Mar 31, 2024
CITADEL ADVISORS LLC----2,200-100.00%-Mar 31, 2024
XTX TOPCO LTD0.01%0.00%18,487-949-4.88%5,814Mar 31, 2024
NEWEDGE ADVISORS, LLC----500-100.00%-Mar 31, 2024
UBS GROUP AG----100-100.00%-Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.----85-100.00%-Mar 31, 2024
ADVISORNET FINANCIAL, INC--5--2,000Mar 31, 2024
ALLWORTH FINANCIAL LP--87--27,000Mar 31, 2024
JPMORGAN CHASE & CO--33100.00%1Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-500500100.00%155,000Mar 31, 2024
RHUMBLINE ADVISERS0.01%-12,1702,46025.33%3,831,000Mar 31, 2024
GROUND SWELL CAPITAL, LLC0.01%0.00%11,15011,150100.00%3,507Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.03%-48,60035,900282.68%15,056Mar 31, 2024

As of Mar 31 2024, Kazia Therapeutics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -2.48M shares of KZIA, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GROUND SWELL CAPITAL, LLC0.01%0.00%11,15011,150100.00%3,507Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-500500100.00%155,000Mar 31, 2024
JPMORGAN CHASE & CO--33100.00%1Mar 31, 2024

Kazia Therapeutics's largest new institutional shareholder by number of shares is GROUND SWELL CAPITAL, LLC, purchased 11.15K shares, valued at $3.51K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----2,475,555-100.00%-Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD----1,821,887-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----140,166-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----18,682-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----2,200-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----500-100.00%-Mar 31, 2024
UBS GROUP AG----100-100.00%-Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.----85-100.00%-Mar 31, 2024

Kazia Therapeutics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -2.48M shares, valued at -, as of undefined.

Kazia Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TRUST FOR PROFESSIONAL MANAGERS0.00%26,411--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%4,948--Feb 29, 2024

Kazia Therapeutics's largest mutual fund holder by % of total assets is "TRUST FOR PROFESSIONAL MANAGERS", owning 26.41K shares, compromising 0.00% of its total assets.

Kazia Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 246-66.67%
31 Dec, 231880.00%
30 Sep, 231011.11%
30 Jun, 23912.50%
31 Mar, 238-11.11%
31 Dec, 22928.57%
30 Sep, 227-36.36%
30 Jun, 221110.00%
31 Mar, 2210-
31 Dec, 2110-33.33%
30 Sep, 211536.36%
30 Jun, 211110.00%
31 Mar, 2110-16.67%
31 Dec, 201220.00%
30 Sep, 201066.67%
30 Jun, 206-
31 Mar, 206-25.00%
31 Dec, 19814.29%
30 Sep, 197-
30 Jun, 19740.00%
31 Mar, 195-
31 Dec, 185-28.57%
30 Sep, 187-
30 Jun, 18716.67%
31 Mar, 18650.00%
31 Dec, 174-

As of 31 Mar 24, 6 institutions are holding Kazia Therapeutics's shares, representing a decrease of -66.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2461,365-98.74%
31 Dec, 234,883,3381959.24%
30 Sep, 23237,143-16.63%
30 Jun, 23284,4444.77%
31 Mar, 23271,491-36.29%
31 Dec, 22426,146-11.34%
30 Sep, 22480,66363.33%
30 Jun, 22294,297-16.16%
31 Mar, 22351,036-17.39%
31 Dec, 21424,950-17.56%
30 Sep, 21515,465-1.26%
30 Jun, 21522,02121.08%
31 Mar, 21431,151-20.46%
31 Dec, 20542,07722.62%
30 Sep, 20442,09442.70%
30 Jun, 20309,80318.74%
31 Mar, 20260,8994.20%
31 Dec, 19250,372-1.20%
30 Sep, 19253,41811.53%
30 Jun, 19227,22210.75%
31 Mar, 19205,165-0.36%
31 Dec, 18205,915-1.86%
30 Sep, 18209,82589.66%
30 Jun, 18110,63216.86%
31 Mar, 1894,66911.86%
31 Dec, 1784,629-

Kazia Therapeutics (KZIA) has 61.37K shares outstanding as of 31 Mar 24, down -98.74% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.03%0.70%
31 Dec, 232.19%68.36%
30 Sep, 231.79%38.83%
30 Jun, 232.15%51.12%
31 Mar, 232.05%19.80%
31 Dec, 223.22%24.43%
30 Sep, 223.63%73.52%
30 Jun, 222.22%31.64%
31 Mar, 222.65%25.75%
31 Dec, 213.21%16.72%
30 Sep, 214.38%22.26%
30 Jun, 214.44%45.34%
31 Mar, 213.13%20.23%
31 Dec, 203.93%10.74%
30 Sep, 206.05%33.65%
30 Jun, 204.24%33.25%
31 Mar, 203.57%30.40%
31 Dec, 193.43%17.65%
30 Sep, 194.41%28.23%
30 Jun, 193.95%31.04%
31 Mar, 193.57%27.83%
31 Dec, 183.58%19.03%
30 Sep, 184.34%82.93%
30 Jun, 182.29%59.72%
31 Mar, 181.96%63.94%
31 Dec, 171.75%-

As of 31 Mar 24, Kazia Therapeutics is held by 0.03% institutional shareholders, representing a 0.70% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 244-66.67%
31 Dec, 2312500.00%
30 Sep, 232-33.33%
30 Jun, 233-
31 Mar, 233-57.14%
31 Dec, 22740.00%
30 Sep, 22566.67%
30 Jun, 223-25.00%
31 Mar, 224-20.00%
31 Dec, 215-16.67%
30 Sep, 216-14.29%
30 Jun, 21775.00%
31 Mar, 214-42.86%
31 Dec, 207-
30 Sep, 207133.33%
30 Jun, 20350.00%
31 Mar, 202-50.00%
31 Dec, 194100.00%
30 Sep, 192-33.33%
30 Jun, 193200.00%
31 Mar, 191-
31 Dec, 181-66.67%
30 Sep, 183-
30 Jun, 183-
31 Mar, 183-25.00%
31 Dec, 174-

4 institutional shareholders have increased their position in KZIA stock as of 31 Mar 24 compared to 12 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--100.00%
31 Dec, 231-50.00%
30 Sep, 232-
30 Jun, 23--100.00%
31 Mar, 23350.00%
31 Dec, 222-
30 Sep, 222-60.00%
30 Jun, 22566.67%
31 Mar, 223-
31 Dec, 21350.00%
30 Sep, 212100.00%
30 Jun, 211-66.67%
31 Mar, 21350.00%
31 Dec, 202100.00%
30 Sep, 201-
30 Jun, 20--100.00%
31 Mar, 201-
31 Dec, 19--100.00%
30 Sep, 191-
30 Jun, 191-
31 Mar, 191-
31 Dec, 181-50.00%
30 Sep, 182-
30 Jun, 18--100.00%
31 Mar, 181-
31 Dec, 17--

- institutional shareholders have reduced their position in KZIA stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 246-66.67%61,365-98.74%0.03%0.70%4-66.67%--100.00%
31 Dec, 231880.00%4,883,3381959.24%2.19%68.36%12500.00%1-50.00%
30 Sep, 231011.11%237,143-16.63%1.79%38.83%2-33.33%2-
30 Jun, 23912.50%284,4444.77%2.15%51.12%3---100.00%
31 Mar, 238-11.11%271,491-36.29%2.05%19.80%3-57.14%350.00%
31 Dec, 22928.57%426,146-11.34%3.22%24.43%740.00%2-
30 Sep, 227-36.36%480,66363.33%3.63%73.52%566.67%2-60.00%
30 Jun, 221110.00%294,297-16.16%2.22%31.64%3-25.00%566.67%
31 Mar, 2210-351,036-17.39%2.65%25.75%4-20.00%3-
31 Dec, 2110-33.33%424,950-17.56%3.21%16.72%5-16.67%350.00%
30 Sep, 211536.36%515,465-1.26%4.38%22.26%6-14.29%2100.00%
30 Jun, 211110.00%522,02121.08%4.44%45.34%775.00%1-66.67%
31 Mar, 2110-16.67%431,151-20.46%3.13%20.23%4-42.86%350.00%
31 Dec, 201220.00%542,07722.62%3.93%10.74%7-2100.00%
30 Sep, 201066.67%442,09442.70%6.05%33.65%7133.33%1-
30 Jun, 206-309,80318.74%4.24%33.25%350.00%--100.00%
31 Mar, 206-25.00%260,8994.20%3.57%30.40%2-50.00%1-
31 Dec, 19814.29%250,372-1.20%3.43%17.65%4100.00%--100.00%
30 Sep, 197-253,41811.53%4.41%28.23%2-33.33%1-
30 Jun, 19740.00%227,22210.75%3.95%31.04%3200.00%1-
31 Mar, 195-205,165-0.36%3.57%27.83%1-1-
31 Dec, 185-28.57%205,915-1.86%3.58%19.03%1-66.67%1-50.00%
30 Sep, 187-209,82589.66%4.34%82.93%3-2-
30 Jun, 18716.67%110,63216.86%2.29%59.72%3---100.00%
31 Mar, 18650.00%94,66911.86%1.96%63.94%3-25.00%1-
31 Dec, 174-84,629-1.75%-4---

Kazia Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell25,400$6.02$153.03K409,671
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell23,922$6.01$143.69K385,749
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell62,591$6.17$386.34K473,580
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell37,409$6.18$231.24K436,171
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell1,100$6.04$6.64K435,071
Oct 17, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell90,025$6.21$559.21K536,171
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.90$4.45K629,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.05$4.53K628,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.10$4.55K628,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.15$4.58K627,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.21$4.61K627,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.03$4.51K626,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.00$4.00K626,196
Jul 31, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,531,633$1.16$5.26M20,323,053
Mar 27, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$4.90$34.28K3,158,284
Sep 11, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy435,039$7.76$3.38M3,151,284
Jul 12, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy200,000$8.39$1.68M2,716,245
Jul 02, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy24,100$8.40$202.44K2,516,245
Jun 26, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$8.60$60.18K2,492,145
Jun 22, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,183$8.48$35.46K2,485,145

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 31, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,531,633$1.16$5.26M20,323,053
Mar 27, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$4.90$34.28K3,158,284
Sep 11, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy435,039$7.76$3.38M3,151,284
Jul 12, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy200,000$8.39$1.68M2,716,245
Jul 02, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy24,100$8.40$202.44K2,516,245
Jun 26, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$8.60$60.18K2,492,145
Jun 22, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,183$8.48$35.46K2,485,145

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell25,400$6.02$153.03K409,671
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell23,922$6.01$143.69K385,749
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell62,591$6.17$386.34K473,580
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell37,409$6.18$231.24K436,171
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell1,100$6.04$6.64K435,071
Oct 17, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell90,025$6.21$559.21K536,171
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.90$4.45K629,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.05$4.53K628,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.10$4.55K628,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.15$4.58K627,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.21$4.61K627,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.03$4.51K626,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.00$4.00K626,196

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell25,400$6.02$153.03K409,671
Nov 06, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell23,922$6.01$143.69K385,749
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell62,591$6.17$386.34K473,580
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell37,409$6.18$231.24K436,171
Oct 29, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell1,100$6.04$6.64K435,071
Oct 17, 2013AUSTIN JOSIAH T10 percent owner-S-SaleSell90,025$6.21$559.21K536,171
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.90$4.45K629,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.05$4.53K628,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.10$4.55K628,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.15$4.58K627,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.21$4.61K627,196
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$9.03$4.51K626,696
Feb 27, 2013AUSTIN JOSIAH Tdirector, 10 percent owner S-SaleSell500$8.00$4.00K626,196
Jul 31, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,531,633$1.16$5.26M20,323,053
Mar 27, 2008AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$4.90$34.28K3,158,284
Sep 11, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy435,039$7.76$3.38M3,151,284
Jul 12, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy200,000$8.39$1.68M2,716,245
Jul 02, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy24,100$8.40$202.44K2,516,245
Jun 26, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy7,000$8.60$60.18K2,492,145
Jun 22, 2007AUSTIN JOSIAH T10 percent owner-P-PurchaseBuy4,183$8.48$35.46K2,485,145

The last insider sell of Kazia Therapeutics's stock was made by AUSTIN JOSIAH T on Nov 06 2013, selling 25,400 shares at $6.02 per share (valued at $153.03K). The last insider buy of KZIA was made by AUSTIN JOSIAH T on Jul 31 2008, buying 4,531,633 shares at $1.16 per share (worth $5.26M).

Kazia Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2013-6-
Q1 2013-7-
Q4 20121250.00%
Q2 201221200.00%
Q4 20111--
Q3 20111--
Q2 20111--
Q3 20082--
Q1 20081--
Q3 20072--
Q2 200730--
Q1 200716--
Q4 200626--
Q3 20068--
Q2 200681800.00%
Q1 2006-1-
Q4 2003-1-

0 total buy trades, and 6 total sell trades (buy/sell ratio of 0.00%) were made by Kazia Therapeutics's insiders, as of Q4 2013.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2013-6-
Q1 2013-7-
Q4 2012---
Q2 2012---
Q4 2011---
Q3 2011---
Q2 20111--
Q3 20082--
Q1 20081--
Q3 20072--
Q2 200730--
Q1 200716--
Q4 200626--
Q3 20068--
Q2 20068--
Q1 2006---
Q4 2003---

As of Q4 2013, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Kazia Therapeutics's stocks.

Kazia Therapeutics Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
OKYOOKYO Pharma Limited
QNRXQuoin Pharmaceuticals, Ltd.
SPROSpero Therapeutics, Inc.
MREOMereo BioPharma Group plc
QSIQuantum-Si incorporated
HCWBHCW Biologics Inc.
OCULOcular Therapeutix, Inc.
SEERSeer, Inc.
NLSPNLS Pharmaceutics AG
RNXTRenovoRx, Inc.
CADLCandel Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
SLSSELLAS Life Sciences Group, Inc.
NRIXNurix Therapeutics, Inc.
KTTAPasithea Therapeutics Corp.
CTMXCytomX Therapeutics, Inc.
ACHLAchilles Therapeutics plc
MNOVMediciNova, Inc.
ASMBAssembly Biosciences, Inc.
ABIOARCA biopharma, Inc.

KZIA Ownership FAQ


Kazia Therapeutics is owned by institutional shareholders (0.03%), insiders (0.00%), and public (99.97%). The largest institutional shareholder of Kazia Therapeutics is MORGAN STANLEY (0.11% of total shares) and the top mutual fund owner is TRUST FOR PROFESSIONAL MANAGERS (0.00% of total shares).

Kazia Therapeutics's major institutional shareholders are MORGAN STANLEY, HSBC HOLDINGS PLC, BNP PARIBAS ARBITRAGE, SNC, XTX TOPCO LTD, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 0.19% of the company's share outstanding.

As of Mar 2024, there are 6 institutional shareholders of Kazia Therapeutics.

MORGAN STANLEY owns 197.85K shares of Kazia Therapeutics, representing 0.11% of the company's total shares outstanding, valued at $61.29K (as of Mar 2024).

As of Mar 2024, HSBC HOLDINGS PLC holds 63.96K shares of Kazia Therapeutics (KZIA), compromising 0.04% of the company, valued at $20.11K.

BNP PARIBAS ARBITRAGE, SNC is the third largest holder of Kazia Therapeutics. The company owns 48.6K of the company's shares outstanding (worth $15.06K).